Seating for this event is limited. For more information, contact Lucinda Lanier. 

Agenda overview

Monday, May 20

1:10–1:50 pm

• David Howard, Emory University                        
  Diffusion of a Cost-Saving Innovation in Health Care: The Case of Outpatient Treatment for Appendicitis

1:50–2:30 pm

• Michael Darden, Johns Hopkins University and NBER           
  Externalities from Medical Innovation: Evidence from Organ Transplantation

2:45–3:25 pm

• Josh Feng, University of Utah Eccles School of Business
  Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization

3:25–4:05 pm

• Jetson Leder-Luis, Boston University and NBER
  Ambulance Taxis: The Impact of Regulation and Litigation on Health Care Fraud

6:30–8:00 pm

• Markus H. Meier, Former Assistant Director in the Federal Trade Commission’s (FTC) Bureau of Competition
  Evening Keynote Address

Tuesday, May 21

9:35–10:15 am

• Abby Alpert, University of Pennsylvania and NBER
  Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market

10:15–10:55 am

• William Comanor, UCLA Fielding School of Public Health
  The Generic Drug Global Supply Chain: Economic Costs and Benefits

11:10–11:50 am

• Bhaven Sampat, Arizona State University and NBER
  The Feasibility and Desirability of Using Bayh-Dole March-In Rights to Reduce Prices on NIH-Funded Drugs

11:50–12:30 pm

• Danea Horn, Stanford University
  The Incentive to Treat: Physician Agency and the Expansion of the 340B Drug Pricing Program

1:30–2:10 pm

• Atul Gupta, University of Pennsylvania and NBER
  The Impact of Privatization: Evidence from the Hospital Sector

2:10–2:50 pm

• Natalia Serna, Stanford University
  The Role of Hospital Networks in Individual Mortality

2:50–3:30 pm

• Ashvin Gandhi, UCLA Anderson and NBER
  Healthcare Provider Bankruptcies